Shwu-Maan Lee

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 6

Top Topics

Protein Protein

Clinical Evaluation

Staphylococcus Aureus

High Throughput

Top Venues

Malaria journal

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hasmik Manukyan, Manjari Lal, Changcheng Zhu, Olga Singh, Tsai-Lien Lin, Erman Tritama, Konstantin Chumakov, Shwu-Maan Lee, Majid Laassri
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine. Viruses 16 (6) (2024)
Hasmik Manukyan, Manjari Lal, Changcheng Zhu, Olga Singh, Tsai-Lien Lin, Erman Tritama, Konstantin Chumakov, Shwu-Maan Lee, Majid Laassri
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine. Viruses 16 (6) (2024)
Hasmik Manukyan, Manjari Lal, Changcheng Zhu, Olga Singh, Tsai-Lien Lin, Erman Tritama, Konstantin Chumakov, Shwu-Maan Lee, Majid Laassri
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine. Viruses 16 (6) (2024)
Shwu-Maan Lee, John M Hickey, Kazutoyo Miura, Sangeeta B Joshi, David B Volkin, C Richter King, Jordan L Plieskatt
A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system. Scientific reports 10 (1) (2020)
Shwu-Maan Lee, Yimin Wu, John M Hickey, Kazutoyo Miura, Neal Whitaker, Sangeeta B Joshi, David B Volkin, C Richter King, Jordan Plieskatt
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate. Malaria journal 18 (1) (2019)
Shwu-Maan Lee, Chia-Kuei Wu, Jordan Plieskatt, David H McAdams, Kazutoyo Miura, Chris Ockenhouse, C Richter King
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates. Malaria journal 15 (1) (2016)